Clinical Trials Directory

Trials / Completed

CompletedNCT05324098

Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

Leveraging Technology (STAND-T) to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This clinical trial studies a digital platform, the supportive therapy in androgen deprivation (STAND-T), in achieving equity for men undergoing treatment with androgen deprivation therapy for prostate cancer. STAND-T is a digital platform that provides prostate health information, evidence-based materials and resources. STAND-T may help improve health, address symptoms, and promote equity in men with prostate cancer.

Detailed description

PRIMARY OBJECTIVE: I. To assess study feasibility of the STAND-T program at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) and Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) genitourinary (GU) medical, surgical, and radiation oncology practices. SECONDARY OBJECTIVE: I. To measure preliminary estimates of acceptability and usage of a digital platform, STAND-T. EXPLORATORY OBJECTIVE: I. To describe diet (e.g., fruit and vegetable intake), lifestyle (e.g., moderate to vigorous exercise, smoking status), clinical (symptoms e.g., fatigue), and health related quality of life (QoL) outcomes (e.g., sleep disturbance), physiologic measures (body mass index, BMI) at baseline and change in these metrics from baseline to 3 months post-intervention. OUTLINE: Patients review educational material and resources via online STAND-T platform. Patients also receive interactive text messages for 3 months. After completion of study, patients are followed up at 3 months.

Conditions

Interventions

TypeNameDescription
OTHERSTAND-T platformInternet-based intervention comprised of evidence-based, patient materials and resources
OTHERSurvey AdministrationSatisfaction and follow-up surveys will be administered to participants
OTHERText MessagesParticipants will receive periodic text messages

Timeline

Start date
2022-03-08
Primary completion
2023-07-31
Completion
2023-07-31
First posted
2022-04-12
Last updated
2024-06-10

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05324098. Inclusion in this directory is not an endorsement.